People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Circinus Medical Technology LLC | — | Biotechnology | Series A | $9.8M | $46.1M | 2020 |
| DeepDyve, Inc. | — | Other | Seed | $1.5M | $20.9M | 2009 |
John Dorman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Dorman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Samberg | 1 | 5 |
| Gregory Stanger | 1 | 3 |
| David Bovenzi | 1 | 3 |
| Linda Sonntag | 1 | 2 |
| Thomas Bonadio | 1 | 2 |
| Rafael Ortiz | 1 | 2 |
| William Park | 1 | 2 |
| Joan Cummings | 1 | 1 |
| Raphael Ortiz | 1 | 1 |
| Qianjin Hu | 1 | 1 |
| Mathew Ray | 1 | 1 |
| Patrick West | 1 | 1 |
| Ted Dunning | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.